TL;DR
Some health plans cover weight-loss drugs. Many exclude them or cover a GLP-1 only for another FDA-approved use, such as type 2 diabetes. Check the exact drug, diagnosis, plan document, formulary, prior authorization rules, pharmacy, and benefit year before relying on a carrier name or state law.
Does insurance cover weight loss drugs? The short answer

Yes, some insurance covers weight-loss drugs in the USA. Commercial plans, Medicaid programs, Medicare pathways, and public employee plans may cover certain drugs for defined uses. Many plans exclude drugs used only for weight loss.
A carrier logo does not settle the question. Coverage depends on the legal plan, drug, diagnosis, pharmacy benefit, formulary, employer exclusions, and effective date.
We recommend five checks:
- Exact drug and dose.
- FDA-approved use tied to the prescription.
- Plan and funding type.
- Formulary and exclusion terms.
- Prior authorization and pharmacy claim rules.
Last reviewed: November 4, 2026. Formularies, laws, prices, drug supply, and service areas can change. Verify current terms before treatment or enrollment.
What GLP-1 means
GLP-1 medicines act on hormone pathways involved in blood sugar, digestion, and appetite. Some products treat type 2 diabetes. Others have FDA approval for chronic weight management.
These are prescription drugs. They are not over-the-counter supplements.
Products in the class are not interchangeable. Semaglutide, tirzepatide, and liraglutide have different brands, labels, doses, and schedules. Our GLP-1 medications list by active ingredient separates those details.
Coverage is not the same as low cost
Three separate decisions apply:
- The drug appears on the formulary.
- The insurer approves the prior authorization.
- The pharmacy processes the claim at an affordable price.
A covered drug can still have a deductible, coinsurance, nonpreferred tier, quantity limit, or restricted pharmacy network. Formulary placement alone does not show the final cost.
Why a plan may cover Ozempic but reject Wegovy
The FDA-approved use often drives the decision. A plan may cover Ozempic for type 2 diabetes while excluding Wegovy for chronic weight management.
| Brand | Active ingredient | Main FDA-approved use relevant to coverage | Common coverage issue |
|---|---|---|---|
| Wegovy | Semaglutide | Chronic weight management for eligible adults and patients age 12 and older; certain cardiovascular-risk reduction use in adults | Obesity-drug exclusion or prior authorization |
| Zepbound | Tirzepatide | Chronic weight management in adults; obstructive sleep apnea in adults with obesity | Exclusion, diagnosis limits, or step therapy |
| Saxenda | Liraglutide | Chronic weight management for eligible adults and patients age 12 and older who meet label requirements | Daily dosing, prior authorization, or nonpreferred tier |
| Ozempic | Semaglutide | Type 2 diabetes and other uses stated in its current adult label | Weight-loss-only claims may be denied |
| Mounjaro | Tirzepatide | Type 2 diabetes under its current label | Diagnosis verification |
| Rybelsus | Semaglutide | Type 2 diabetes under its current label | Weight-loss-only use may not qualify |
The label must be checked on the prescription date. Off-label prescribing can be lawful, but it does not require an insurer to pay. Patients should never misstate a diagnosis or ask a clinician to code a condition they do not have.
Drugs approved for chronic weight management
Wegovy, Zepbound, and Saxenda have FDA-approved weight-management indications. Each label sets its own age, health, dosing, and eligibility terms.
FDA approval does not create plan coverage. The plan may still exclude obesity drugs, require prior authorization, or prefer another product. Our Saxenda weight-loss guide explains its dosing, costs, and safety in more detail.
Diabetes drugs prescribed off label for weight loss
Ozempic, Mounjaro, and Rybelsus are associated with active ingredients also found in weight-management treatment. Their brand labels and approved uses differ.
That difference can change the claim result. Verify the product and diagnosis rather than asking whether the plan covers “GLP-1 drugs” as one class. The same issue can arise when assessing GLP-1 treatment for PCOS, where prescribing and coverage may involve off-label use.
Medicare and other approved indications
Medicare treatment of weight-loss drugs depends on current federal law, the product’s approved use, and the Part D or Medicare Advantage drug plan. Coverage may be possible when a drug is prescribed for another covered FDA-approved indication rather than weight loss alone.
Do not assume Medicare always covers or never covers a named GLP-1. Check the current formulary, diagnosis criteria, prior authorization form, and benefit year.
Which plan rules apply to you?

Start with the plan type:
- Employer plan: Ask whether it is fully insured or self-funded.
- Marketplace or individual plan: Check the state of issue and policy documents.
- Medicaid: Use the state Medicaid formulary and clinical criteria.
- Medicare: Use the specific Part D or Medicare Advantage documents.
- State employee plan: Use that program’s current benefit and pharmacy documents.
Get the legal plan name, funding type, pharmacy benefit manager, and benefit year. No insurer can be called the best without those facts.
Formularies and employer exclusions can change at renewal. Some terms can also change during the year where the contract and law permit.
Fully insured employer and marketplace plans
State insurance rules may apply to fully insured plans issued in that state. They do not make every drug payable.
Check:
- The policy or certificate of coverage.
- Summary of Benefits and Coverage.
- Current formulary.
- Prior authorization criteria.
- Obesity-drug or weight-loss-treatment exclusions.
- Employer amendments or riders.
Self-funded employer plans and ERISA
Many state insurance mandates do not control self-funded employer benefits governed by federal ERISA rules. A state GLP-1 law may therefore have no effect on the plan.
Ask human resources or the plan administrator: “Is this plan self-funded, and who makes pharmacy benefit decisions?” Request the Summary Plan Description, pharmacy benefit terms, and formal denial notice before appealing.
Medicaid, Medicare, and state employee plans
Keep these programs separate. Each uses different statutes, budgets, formularies, and clinical criteria.
A state decision covering its employees does not prove that Medicaid, marketplace plans, or private employers cover the same drug. Medicaid GLP-1 coverage can also differ by state, diagnosis, age, and preferred-drug rules.
States that mandate GLP-1 coverage: a source-based tracker
There is no honest basis for claiming that every plan in a named state must cover every GLP-1 for weight loss. State actions often apply only to Medicaid, state employees, individual policies, or fully insured plans. Self-funded employer plans may fall outside the rule.
The supplied research did not include the primary state laws, budgets, agency notices, or plan documents required to verify a 51-jurisdiction mandate list. We therefore mark each entry Not identified in supplied primary evidence rather than infer a mandate from secondary pages.
| State or district | Verified action, bill, or statute | Status and dates | Covered population, plan, diagnosis, drugs, and exclusions | Official source | Self-funded plans | Review and change note |
|---|---|---|---|---|---|---|
| Alabama | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Alaska | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Arizona | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Arkansas | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| California | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Colorado | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Connecticut | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Delaware | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| District of Columbia | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Florida | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Georgia | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Hawaii | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Idaho | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Illinois | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Indiana | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Iowa | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Kansas | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Kentucky | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Louisiana | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Maine | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Maryland | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Massachusetts | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Michigan | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Minnesota | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Mississippi | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Missouri | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Montana | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Nebraska | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Nevada | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| New Hampshire | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| New Jersey | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| New Mexico | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| New York | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| North Carolina | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| North Dakota | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Ohio | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Oklahoma | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Oregon | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Pennsylvania | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Rhode Island | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| South Carolina | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| South Dakota | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Tennessee | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Texas | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Utah | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Vermont | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Virginia | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Washington | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| West Virginia | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Wisconsin | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
| Wyoming | Not identified | — | Not established | Not supplied | Not established | 2026-11-04; baseline |
“Not identified” does not mean no policy exists. It means no qualifying primary source was provided to support a broader claim.
How to read the tracker labels
Use these labels when checking state action:
- Enacted law: Passed and signed legislation.
- Signed budget provision: Coverage language tied to a budget period.
- Pending bill: Proposed law, not a mandate.
- Failed bill: Did not become law.
- Agency policy: Administrative rule or benefit policy.
- Medicaid action: Applies to that state’s Medicaid program.
- State employee benefit decision: Applies to the named employee plan.
One-year budget language is not the same as a permanent statute.
Who each state action covers
Read the population clause before the drug clause. Determine whether the action covers Medicaid, state employees, marketplace plans, individual policies, or fully insured employer plans.
Then check the covered use. A rule may apply to diabetes, obesity, cardiovascular risk, sleep apnea, or one named drug. It may not cover weight loss alone.
Tracker maintenance and evidence rules
Each entry should link to a legislature, governor, Medicaid agency, insurance department, or public employee plan. Press releases and introduced bills do not prove active coverage.
Review entries after legislative sessions, budget enactments, Medicaid formulary changes, and employee plan renewals. Archive replaced sources and flag rules that have not taken effect.
How to check your exact drug, price, and pharmacy
The same process works for Blue Cross, Sutter-related plans, and other carriers. Do not rely on a carrier-wide answer.
Search the formulary and Summary of Benefits and Coverage for:
- The exact brand and dose.
- “Anti-obesity agents.”
- “Weight-loss drugs.”
- “Obesity treatment.”
- Benefit exclusions.
- Prior authorization and quantity limits.
An insurer and pharmacy can both appear correct. The insurer may confirm general formulary status while the pharmacy submits a different National Drug Code, quantity, days’ supply, or out-of-network location.
Calculate the monthly total:
Drug copay or coinsurance + unmet deductible + visits + labs + membership fees + pharmacy or shipping charges.
For a product-specific example, review our Zepbound cost breakdown.
What to ask the insurer
Use this script by phone and secure portal:
Is this exact drug and National Drug Code covered for my diagnosis during this benefit year? What is its formulary tier? Does it require prior authorization, step therapy, or a quantity limit? What deductible and coinsurance apply? Which pharmacies are in network? Does my plan or employer exclude obesity drugs? What exception, appeal, and external-review rights apply?
Record the date, representative, reference number, and benefit year. Treat the answer as verification, not a guarantee that the claim will pay.
What to ask the pharmacy
Ask for:
- Rejection code.
- Submitted National Drug Code.
- Quantity and days supplied.
- Pharmacy network status.
- Prior authorization status for that product.
- Expected cost after the claim processes.
Request a new claim only after the insurer or prescriber corrects the stated issue.
Why covered can still mean hundreds of dollars
A deductible may require payment before the plan contributes. A nonpreferred tier may use higher coinsurance. An out-of-network pharmacy can produce a different price.
Manufacturer assistance may have eligibility and use limits. A formulary listing is not an affordable-price guarantee.
Prior authorization and refill approval
Prior authorization is a record-based test against plan rules. Common requirements include BMI, related conditions, chart notes, lab results, prior treatment, diet and activity records, and step therapy.
Criteria differ by plan. Use the current form. An initial approval may last only a few months.
Records to gather before submission
Collect:
- Weight and BMI history.
- Diagnoses and related conditions.
- Current medicines.
- Prior weight-loss treatments.
- Adverse effects or contraindications.
- Relevant laboratory results.
- Diet and activity program records, if required.
Match each item to the written criteria. Confirm the prescriber submits the correct drug, dose, diagnosis, and form.
Step therapy and exceptions
Step therapy requires a patient to try a plan-preferred treatment before the requested drug.
An exception request may document treatment failure, intolerance, contraindication, or another ground recognized by the plan. Do not skip a required step unless the plan approves an exception.
What you may need for reauthorization
Check the approval end date before the last authorized refill. Ask about required weight change, adherence records, refill history, follow-up visits, and current chart notes.
Submit the current reauthorization form before the deadline when allowed. Prior approval does not guarantee renewal.
What to do after a denial or unaffordable quote
First identify the denial type:
- Missing information.
- Medical-necessity denial.
- Formulary restriction.
- Class exclusion.
- Pharmacy claim error.
Get the written denial. Read the stated reason. Fix factual gaps, request an exception if allowed, file an internal appeal, and check external-review rights.
More chart notes may fix a missing-BMI denial. They may not change a clear class exclusion. A state mandate may also fail to reach a self-funded employer plan.
Build an appeal file
Keep copies of:
- Denial notice and plan criteria.
- Prescription and chart notes.
- Lab results.
- Prior treatment records.
- Receipts.
- Portal messages.
- Fax confirmations.
- Call reference numbers.
Use the deadline and address printed on the denial. Ask whether expedited review is available when delay may affect care. Eligibility varies.
A transparent cash-pay route through Temi
Cash pay can remove insurance claim uncertainty, but it does not fit every patient. Compare the full recurring price, not a teaser rate.
Temi provides online prescription support and medication management through one care platform. Current prices, included services, membership terms, medication source, refill process, separate costs, state availability, and shipping terms must be confirmed on the site before purchase.
Treatment requires clinical review. Completing an intake does not guarantee a prescription. Eligibility, fulfillment, supply, service areas, insurance reimbursement, and savings can vary.
FDA-approved brands and compounded products are not the same
A compounded product is not the generic version of an FDA-approved brand. Compounding involves separate legal, safety, quality, sourcing, and availability questions.
Federal rules, state rules, and shortage conditions can change. Verify the pharmacy, active ingredient, prescriber, testing claims, current shortage status, and applicable rules before treatment.
Questions about GLP-1 coverage and access
Does Sutter Health offer GLP-1 medication for weight loss?
There is no reliable system-wide yes or no without a current primary source. Coverage and prescribing may vary by medical group, health plan, employer benefit, drug, diagnosis, and service area.
Check the plan formulary and benefit exclusions. Ask the clinical office whether it evaluates patients for weight-management medication.
What is the number one weight-loss pill over the counter?
GLP-1 drugs are prescription medicines, not over-the-counter pills. We do not rank supplements as substitutes for prescription treatment.
Discuss supplement safety, ingredients, and drug interactions with a licensed clinician. “Natural” does not establish safety or effectiveness.
Where can I get GLP-1 care without a membership fee?
Compare prescription, clinical visit, lab, shipping, refill, and cancellation charges. Ask whether the quoted rate requires a recurring membership.
Temi’s current fee structure and state availability should be confirmed before intake. Clinical review is required, and an intake does not guarantee prescribing or fulfillment.
Which insurance will cover GLP-1 drugs in 2027?
Carrier-level coverage for 2027 cannot be guaranteed in advance. Review the 2027 formulary, exclusions, Summary of Benefits and Coverage, prior authorization criteria, and employer amendments.
Do not choose a plan from an old drug list or carrier-wide claim. Confirm the exact plan and effective date.
FAQ
Does insurance cover weight-loss drugs prescribed online?
Sometimes. The prescription’s origin does not decide coverage. The plan will assess the exact product, diagnosis, prescriber, pharmacy, benefit terms, and prior authorization records. Confirm that the clinician and pharmacy meet network rules. An online prescription does not guarantee an approved claim or low price.
What is GLP-1?
GLP-1 is a hormone involved in blood sugar control, digestion, and appetite. GLP-1 medicines act on this pathway. Products differ by active ingredient, FDA-approved use, dose, and schedule. They require a prescription and clinical review. They are not over-the-counter vitamins or weight-loss supplements.
Does Blue Cross Blue Shield cover Wegovy or Zepbound?
Some Blue Cross Blue Shield plans may cover them, while others exclude weight-loss drugs. Local companies, employers, and plan types use different rules. Check the exact plan formulary, obesity-drug exclusion, prior authorization form, deductible, pharmacy network, and benefit year. A Blue Cross card alone does not answer the question.
Can I appeal when my employer excludes all weight-loss drugs?
You may have appeal or exception rights, but an appeal may not override a clear benefit exclusion. Request the plan document, funding type, denial notice, and exclusion language. Ask about formulary exceptions, medical-necessity exceptions, internal appeals, and external review. Confirm whether state insurance law applies to the plan.
Where can I get GLP-1 care without a membership fee?
Start by comparing all recurring charges, including visits, medication, labs, shipping, refills, and cancellation terms. Temi publishes its current access and pricing terms online, which should be checked before intake. Treatment remains subject to clinical review, state availability, prescription eligibility, supply, and fulfillment requirements.
Review your coverage and cash-pay options
Gather your formulary, denial notice, prescription, and latest chart notes. Then compare the full insurance cost with the current cash-pay terms at Temi.




